US Bancorp’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-24,100
Closed -$29.6K 4126
2025
Q2
$29.6K Sell
24,100
-9,387
-28% -$10.2K ﹤0.01% 3019
2025
Q1
$36.8K Sell
33,487
-6,168
-16% -$7.13K ﹤0.01% 2891
2024
Q4
$35.9K Hold
39,655
﹤0.01% 2907
2024
Q3
$39.1K Buy
+39,655
New +$38.1K ﹤0.01% 2858
2023
Q1
Sell
-601
Closed -$1.3K 4140
2022
Q4
$1.3K Sell
601
-104
-15% -$856 ﹤0.01% 3880
2022
Q3
$8K Buy
+705
New +$8.75K ﹤0.01% 3444
2022
Q1
Sell
-1,500
Closed -$17K 4112
2021
Q4
$17K Hold
1,500
﹤0.01% 3201
2021
Q3
$19K Sell
1,500
-262
-15% -$2.41K ﹤0.01% 3155
2021
Q2
$14K Buy
1,762
+184
+12% +$1.59K ﹤0.01% 3288
2021
Q1
$15K Sell
1,578
-218
-12% -$2.2K ﹤0.01% 3144
2020
Q4
$17K Buy
1,796
+881
+96% +$8.68K ﹤0.01% 2978
2020
Q3
$11K Sell
915
-80
-8% -$1.06K ﹤0.01% 3046
2020
Q2
$13K Buy
995
+245
+33% +$3.08K ﹤0.01% 3005
2020
Q1
$8K Hold
750
﹤0.01% 3092
2019
Q4
$12K Buy
750
+500
+200% +$10.1K ﹤0.01% 3042
2019
Q3
$4K Buy
+250
New +$4.97K ﹤0.01% 3281

Other funds holding GOSS

US Bancorp's GOSS Position: Q3 2025 in Review

US Bancorp sold out of Gossamer Bio (GOSS) in Q3 2025, closing a stake of 24,100 shares — an estimated $29.6K sold.

US Bancorp first reported a position in GOSS in Q3 2019 and held it in 16 quarters. The position peaked at $39.1K in Q3 2024. 164 funds tracked by Wall St. Rank hold GOSS as of Q3 2025.

  • US Bancorp reported no remaining Gossamer Bio position as of Q3 2025 after selling out during the quarter.
  • US Bancorp sold 24,100 Gossamer Bio shares in Q3 2025, an estimated $29.6K.
  • US Bancorp first reported a position in Gossamer Bio in Q3 2019 and held it in 16 quarters.
  • US Bancorp's Gossamer Bio position peaked at $39.1K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2025.

Based on US Bancorp's 13F filing for Q3 2025, filed 12 Nov 2025.